CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 140 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2016. The put-call ratio across all filers is 1.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,422,000 | +11.6% | 12,730 | 0.0% | 0.01% | -8.3% |
Q1 2017 | $1,274,000 | -15.7% | 12,730 | -7.9% | 0.01% | -25.0% |
Q4 2016 | $1,511,000 | -4.4% | 13,820 | +8.1% | 0.02% | -11.1% |
Q3 2016 | $1,581,000 | +17.0% | 12,780 | 0.0% | 0.02% | +20.0% |
Q2 2016 | $1,351,000 | +3.6% | 12,780 | +11.9% | 0.02% | 0.0% |
Q1 2016 | $1,304,000 | – | 11,420 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ariose Capital Management Ltd | 88,655 | $10,149,000 | 9.57% |
WARBURG PINCUS LLC | 4,087,200 | $467,903,000 | 8.91% |
RUDMAN ERROL M | 64,001 | $7,327,000 | 4.96% |
INDUS CAPITAL PARTNERS, LLC | 378,518 | $43,333,000 | 4.22% |
OBERWEIS ASSET MANAGEMENT INC/ | 90,105 | $10,315,000 | 2.98% |
Ativo Capital Management LLC | 85,623 | $9,802,000 | 2.66% |
Sensato Investors LLC | 113,296 | $12,970,000 | 2.31% |
Cormorant Asset Management, LP | 111,500 | $12,765,000 | 1.92% |
BARING ASSET MANAGEMENT Ltd | 128,784 | $14,743,000 | 1.23% |
Visium Asset Management, LP | 484,619 | $55,479,000 | 0.94% |